Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. [electronic resource]
Producer: 20130212Description: 96-104 p. digitalISSN:- 1524-4636
- Angiotensin II -- metabolism
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Apolipoproteins E -- genetics
- Arteries -- drug effects
- Arterioles -- drug effects
- Atherosclerosis -- genetics
- CX3C Chemokine Receptor 1
- Cell Adhesion
- Cells, Cultured
- Chemokine CX3CL1 -- genetics
- Disease Models, Animal
- Endothelial Cells -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Human Umbilical Vein Endothelial Cells -- metabolism
- Humans
- Interferon-gamma -- metabolism
- Leukocyte Rolling
- Leukocytes -- metabolism
- Losartan -- pharmacology
- Male
- Membrane Glycoproteins -- genetics
- Membrane Proteins -- genetics
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- NADPH Oxidase 2
- NADPH Oxidase 4
- NADPH Oxidase 5
- NADPH Oxidases -- genetics
- NF-kappa B -- metabolism
- RNA Interference
- Receptors, Chemokine -- genetics
- Signal Transduction
- Time Factors
- Transfection
- Tumor Necrosis Factor-alpha -- genetics
- Veins -- drug effects
- Venules -- drug effects
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.